Tal Zvi Zaks Moderna, Inc. (MRNA) insider trading activity

Tal Zvi Zaks is Chief Medical Officer of Moderna, Inc.. Currently has a direct ownership of 0 shares of MRNA, which is worth approximately $0. The most recent transaction as insider was on Jul 08, 2020, when has been sold 20,000 shares (Common Stock) at a price of $61.26 per share, resulting in proceeds of $1,225,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

Tal Zvi Zaks Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 08 2020	SELL Open market or private sale	$1,225,200 $61.26 p/Share	20,000 Reduced 100.0%	0 Common Stock
Jul 08 2020	BUY Exercise of conversion of derivative security	$400,800 $20.04 p/Share	20,000 Added 50.0%	20,000 Common Stock
Jul 07 2020	SELL Open market or private sale	$3,733,070 $59.55 p/Share	62,688 Reduced 100.0%	0 Common Stock
Jul 07 2020	BUY Exercise of conversion of derivative security	$1,055,666 $16.84 p/Share	62,688 Added 50.0%	62,688 Common Stock
Jun 30 2020	SELL Open market or private sale	$2,530,215 $63.65 p/Share	39,752 Reduced 100.0%	0 Common Stock
Jun 30 2020	BUY Exercise of conversion of derivative security	$761,251 $19.15 p/Share	39,752 Added 50.0%	39,752 Common Stock
Jun 23 2020	SELL Open market or private sale	$2,550,488 $64.16 p/Share	39,752 Reduced 100.0%	0 Common Stock
Jun 23 2020	BUY Exercise of conversion of derivative security	$761,251 $19.15 p/Share	39,752 Added 50.0%	39,752 Common Stock
Jun 16 2020	SELL Open market or private sale	$2,581,495 $64.94 p/Share	39,752 Reduced 100.0%	0 Common Stock
Jun 16 2020	BUY Exercise of conversion of derivative security	$761,251 $19.15 p/Share	39,752 Added 50.0%	39,752 Common Stock
Jun 09 2020	SELL Open market or private sale	$2,331,057 $58.64 p/Share	39,752 Reduced 100.0%	0 Common Stock
Jun 09 2020	BUY Exercise of conversion of derivative security	$761,251 $19.15 p/Share	39,752 Added 50.0%	39,752 Common Stock
Jun 02 2020	SELL Open market or private sale	$5,749,343 $58.1 p/Share	98,956 Reduced 100.0%	0 Common Stock
Jun 02 2020	BUY Exercise of conversion of derivative security	$1,503,142 $15.19 p/Share	98,956 Added 50.0%	98,956 Common Stock
May 26 2020	SELL Open market or private sale	$8,320,428 $66.54 p/Share	125,044 Reduced 100.0%	0 Common Stock
May 26 2020	BUY Exercise of conversion of derivative security	$1,653,082 $13.22 p/Share	125,044 Added 50.0%	125,044 Common Stock
May 19 2020	SELL Open market or private sale	$9,773,439 $78.16 p/Share	125,044 Reduced 100.0%	0 Common Stock
May 19 2020	BUY Exercise of conversion of derivative security	$1,526,787 $12.21 p/Share	125,044 Added 50.0%	125,044 Common Stock
May 12 2020	SELL Open market or private sale	$8,129,111 $65.01 p/Share	125,044 Reduced 100.0%	0 Common Stock
May 12 2020	BUY Exercise of conversion of derivative security	$1,526,787 $12.21 p/Share	125,044 Added 50.0%	125,044 Common Stock
May 05 2020	SELL Open market or private sale	$240,790 $50.48 p/Share	4,770 Reduced 100.0%	0 Common Stock
Apr 24 2020	SELL Open market or private sale	$471,500 $47.15 p/Share	10,000 Reduced 67.7%	4,770 Common Stock
Apr 17 2020	SELL Open market or private sale	$488,100 $48.81 p/Share	10,000 Reduced 40.37%	14,770 Common Stock
Apr 13 2020	SELL Open market or private sale	$320,000 $32.0 p/Share	10,000 Reduced 28.76%	24,770 Common Stock
Apr 03 2020	SELL Open market or private sale	$328,100 $32.81 p/Share	10,000 Reduced 22.34%	34,770 Common Stock

Also insider at

ADAP

Adaptimmune Therapeutics PLC Healthcare

Director

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD Healthcare

TZZ

Tal Zvi Zaks

Chief Medical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Value

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Moderna, Inc.

Track Activities on MRNA

Account